[Clinical experience in the treatment of ovarian carcinoma and the role of the nurse during the hemotherapy].
Zaprjanova
P
P
Kostova
I
I
Stancheva
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016190:Carboplatin / Q000009:adverse effects / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy* / Q000451:nursing*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D015251:Epirubicin / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009723:Nurse-Patient Relations; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000451:nursing*; D017239:Paclitaxel / Q000009:adverse effects / Q000627:therapeutic use; D055815:Young Adult
D000970:Antineoplastic Agents; D015251:Epirubicin; D003520:Cyclophosphamide; D016190:Carboplatin; D017239:Paclitaxel; D002945:Cisplatin